- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01948089
Exploring the Long-term Effects of Cognitive Exercise on Cognition After Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Vascular cognitive impairment due to vascular disease and stroke frequently includes problems with attention, working memory and executive functions (e.g., monitoring, planning, and organization).
These deficits are common - 32-73%, and chronic, and interfere with a patients response to rehabilitation, independence in activities of daily living, community re-integration, and overall quality of life after stroke. Attention, memory and executive function impairments can adversely affect the ability to relearn various skills.
Cognitive impairments and their impacts on other components of functioning not only impact on the individual, but can also adversely affect the family via increases in caregiver distress and burden. Thus, the presence of cognitive impairment has wide-reaching impact and deserves effective and consistent intervention similar to the attention devoted to improving function in physical domains.
Cognitive training can improve cognitive function, particularly in those areas known to involved in vascular cognitive impairment, i.e., attentional and executive function. Accumulating evidence indicates that computer-based training can improve cognitive skills in healthy older adults as well as in clinical populations. Attention and working memory training has also been shown to be effective in patients in the chronic phase post stroke.
The investigators propose that specific cognitive training to improve working memory could provide direct benefit to chronic stroke patients. Promising interventions focused on intensive and direct working memory training are emerging and have been shown to generalize to other cognitive domains, such as fluid intelligence.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 4R2
- Dalhousie University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Subjects must: (i) be ≥18 years of age, (ii) have been received the diagnosis of ischemic or hemorrhagic stroke >6 months ago, (iii) be experiencing stroke-related cognitive problems that interfere with daily functioning, (iv) be able to perform a two-step command, (v) live within a 75 km radius of the Queen Elizabeth II
Exclusion Criteria:
- Subjects must not: (i) have moderate or severe receptive aphasia, (ii) have a terminal illness, life-threatening co-morbidity or concomitant neurological or psychiatric illness.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Variable Structured Cognitive Exercise
This training group will consist of 10 randomly assigned participants who will begin the adaptive working memory training task immediately after baseline assessment.
Each participant will receive 30 minutes of cognitive exercise per day, 3 days a week for 10 weeks.
|
This exercise uses the n-back paradigm in which participants are asked to keep track of one or two series of sequentially presented auditory and/or visual stimuli in order to detect targets that match those presented n-items ago in the sequence.
The task begins at 1-back (i.e., watch for targets that match those just presented) and gets harder (e.g., watch for matches with items presented 2 or 3 items ago in the sequence) as performance improves.
The stimuli will vary weekly, and include varying auditory letters or words, or varying visual patterns or faces.
|
|
Experimental: Constant Structured Cognitive Exercise
This training group will consist of 10 randomly assigned participants who will begin the adaptive working memory training task immediately after baseline assessment.
Each participant will receive 30 minutes of cognitive exercise per day, 3 days a week for 10 weeks.
|
This exercise uses the n-back paradigm in which participants are asked to keep track of one or two series of sequentially presented auditory and/or visual stimuli in order to detect targets that match those presented n-items ago in the sequence.
The task begins at 1-back (i.e., watch for targets that match those just presented) and gets harder (e.g., watch for matches with items presented 2 or 3 items ago in the sequence) as performance improves.
The stimuli will remain constant throughout the 10 week intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Flanker Effects at 10 weeks
Time Frame: The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Flanker test [primary study outcome] is a computerized test of selective attention and reaction time that involves a motor response.
The participant needs to focus and identify an item presented on a screen while ignoring task-irrelevant distracters.
Performance on this test has been shown to improve with exercise
|
The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from Baseline Raven's Matrices Scores at 10 weeks
Time Frame: The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Raven's Matrices Test is a measure of non-verbal reasoning ability and fluid intelligence (i.e., ability to solve new problems independently of previously acquired knowledge, which is critical to learning).
This test will examine the far transfer of training to a problem-solving task.
Dual n-back training has shown to improve performance on this test.
|
The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
|
Change from Baseline Montreal Cognitive Assessment Scores at 10 weeks
Time Frame: The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Montreal Cognitive Assessment is a well-known screening tool for mild cognitive impairment.
This test is a measure of overall cognitive abilities.
|
The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
|
Change from Baseline Networks of Attention Battery scores at 10 weeks
Time Frame: The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Networks of Attention battery is a computerized battery that provides performance data on tests of vigilance (simple and choice reaction time), orienting and selection (visual search) and executive control (dual tasking, working memory, inhibition).
This battery will allow the attention and working memory deficits to be characterized for each patient and serve as near and far transfer measures of training effects.
|
The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
|
Change from Baseline Sternberg Digit Memory scores at 10 weeks
Time Frame: The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Sternberg digit memory task is a measure of visual working memory wherein the subject is shown a set of n digits for study.
After a short delay, a digit is shown and the subject is asked to recall whether that item was in the previously viewed set.
This test will examine the near transfer of training to another working memory test.
|
The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
|
Change from Baseline Cognitive Failures Questionnaire Scores at 10 weeks
Time Frame: The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Cognitive Failures Questionnaire is a measure of self-reported deficits in completing simple everyday tasks due to failures in attention, memory, perception, and motor function, for example, "Do you find you forget why you went from one part of the house to the other?"
It has high internal validity (alpha=0.91)
and good test-retest reliability (r= 0.82).
|
The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
|
Change from Baseline Hospital Anxiety and Depression Scale (HADS) at 10 weeks
Time Frame: The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Hospital Anxiety and Depression Scale (HADS) consists of 14 items, divided into two 7-item subscales (Anxiety and Depression).
HADS has been reported to be an 'acceptable' screening tool for anxiety and depression after stroke.
|
The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
|
Cognitive Activities Questionnaire and the Physical Activity Scale for the Elderly (PASE)
Time Frame: Participants will be assessed during the duration of the study, an expected average of 10 weeks
|
Cognitive Activities Questionnaire and the Physical Activity Scale for the Elderly (PASE) will be conducted to determine the extent of cognitive and physical activities, respectively, during the 10-week interval.
|
Participants will be assessed during the duration of the study, an expected average of 10 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Fatigue Severity Scale
Time Frame: Participants will be assessed during the duration of the study, an expected average of 10 weeks
|
The Fatigue Severity Scale is a brief 9-item questionnaire designed to assess patient fatigue.
This scale is commonly used for the stroke population.
|
Participants will be assessed during the duration of the study, an expected average of 10 weeks
|
|
Participant Satisfaction
Time Frame: Participants will be assessed during the duration of the study, an expected average of 10 weeks
|
Participants will be asked a set of structured questions about their response to the training itself - difficulty, enjoyability, response to using a computer, etc.
|
Participants will be assessed during the duration of the study, an expected average of 10 weeks
|
|
Change from Baseline Event Related Potentials using Cortical Activity Electroencephalography at 10 weeks
Time Frame: The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Cortical activity Electroencephalography technology will be used to measure cortical activity.
Stimulus presentation and participant response on the computerized Flanker test will be synchronized with EEG data acquisition.
Numeric 'triggers' will be placed on the continuous EEG waveform corresponding to stimulus presentation and participant response.
Data synchronization is necessary to perform event related potential (ERP) analysis to obtain the P3 component.
150 trials (~5.5 seconds per trial) will be processed using a "SynAmps" response time 128 channel EEG system from 18 scalp electrodes at a sampling rate of 1000 Hz for a total EEG data collection time of ~20 minutes.
Electrodes around the eyes will allow detection and removal of trials with ocular artifacts.
|
The participants will be assessed on session 1 of week 1 and on session 31 of week 10
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Graham C Wilson, BSc, Dalhousie University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Ext-Prim-12
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Phase Stroke Patients
-
Riphah International UniversityNot yet recruitingChronic Stroke PatientsPakistan
-
HealthPartners InstituteRecruitingChronic Stroke PatientsUnited States
-
Stefania CostiArcispedale Santa Maria Nuova-IRCCSCompletedComplex Patients in Rehabilitation PhaseItaly
-
Tel-Aviv Sourasky Medical CenterUnknownCephalic Phase, Oncology PatientsIsrael
-
University of Kansas Medical CenterNot yet recruitingStroke | Chronic Stroke Patients | Chronic Stroke SurvivorsUnited States
-
National Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
National Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blastic Phase Chronic Myelogenous LeukemiaUnited States
-
University of ZurichThermoFisher Scientific Brahms Biomarkers FranceCompletedAcute Phase Biomarkers | Medical ICU Admitted PatientsSwitzerland
-
Biruni UniversityCompletedChronic Stroke Patients | Stroke PatientsTurkey (Türkiye)
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedAccelerated Phase Chronic Myelogenous Leukemia (CML) | Blast Phase Chronic Myelogenous Leukemia (CML) | Chronic Phase Phase Chronic Myelogenous Leukemia (CML) | Philadelphia Chromosome Positive (Ph+) Phase Chronic Myelogenous Leukemia (CML)United States
Clinical Trials on Variable Structured Cognitive Exercise
-
University Hospital of SplitSlovenian Research AgencyUnknownHypertension | Sarcopenia | Muscle AtrophySlovenia
-
Hospital General de México Dr. Eduardo LiceagaNational Council of Science and Technology, Mexico; Universidad Nacional Autonoma... and other collaboratorsUnknownLiver Diseases | Obesity | Metabolic Syndrome | Exercise | Childhood Obesity | Cardiovascular Risk FactorMexico
-
Maharishi Markendeswar University (Deemed to be...Recruiting
-
Istanbul UniversityMedipol University; Istanbul University - Cerrahpasa (IUC)Completed
-
VA Office of Research and DevelopmentCompleted
-
VA Office of Research and DevelopmentCompleted
-
Indonesia UniversityCompletedType 2 Diabetes Mellitus | Oxidative Stress | Resistance Training | Physical Fitness | High-Intensity Interval TrainingIndonesia
-
Weill Medical College of Cornell UniversityHospital for Special Surgery, New YorkCompletedPostoperative ComplicationsUnited States
-
Association for Functional Rehabilitation, Recreation...CompletedGestational Diabetes MellitusCroatia
-
Hong Kong Baptist UniversityRecruitingDepressive SymptomsHong Kong